Wedgewood Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,175
| Closed | -$300K | – | 38 |
|
|
2022
Q4 | $300K | Sell |
4,175
-1,250
| -23% | -$89.8K | 0.06% | 36 |
|
|
2022
Q3 | $385K | Sell |
5,425
-500
| -8% | -$35.5K | 0.07% | 33 |
|
|
2022
Q2 | $456K | Sell |
5,925
-1,000
| -14% | -$77K | 0.08% | 33 |
|
|
2022
Q1 | $505K | Buy |
6,925
+2,250
| +48% | +$164K | 0.07% | 32 |
|
|
2021
Q4 | $291K | Sell |
4,675
-625
| -12% | -$38.9K | 0.04% | 36 |
|
|
2021
Q3 | $313K | Sell |
5,300
-325
| -6% | -$19.2K | 0.04% | 36 |
|
|
2021
Q2 | $375K | Sell |
5,625
-70,210
| -93% | -$4.68M | 0.05% | 36 |
|
|
2021
Q1 | $4.79M | Sell |
75,835
-338,222
| -82% | -$21.3M | 0.74% | 23 |
|
|
2020
Q4 | $25.7M | Sell |
414,057
-25,262
| -6% | -$1.57M | 3.82% | 15 |
|
|
2020
Q3 | $26.5M | Buy |
439,319
+65,538
| +18% | +$3.95M | 4.19% | 12 |
|
|
2020
Q2 | $22M | Buy |
373,781
+114,601
| +44% | +$6.74M | 3.72% | 12 |
|
|
2020
Q1 | $14.4M | Sell |
259,180
-132,262
| -34% | -$7.37M | 2.74% | 16 |
|
|
2019
Q4 | $25.1M | Buy |
+391,442
| New | +$25.1M | 2.55% | 17 |
|